Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

2.3K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.3K
iPS Cell Differentiation01:22

iPS Cell Differentiation

3.0K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.0K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.6K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.6K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Systemic regeneration medicines for muscular dystrophy: progress and challenges in pro-regenerative drug development.

Cell regeneration (London, England)·2026
Same author

DMD-Null mice exhibit severe muscle weakness, impaired regeneration, and deficient satellite cell function.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Dystrophin-gene mutation location influences severity of electroretinogram defects in mouse models of Duchenne muscular dystrophy.

BMC medicine·2026
Same author

RNA Therapeutics for Duchenne Muscular Dystrophy: Exon Skipping, RNA Editing, and Translational Insights from Genome-Edited Microminipig Models.

International journal of molecular sciences·2026
Same author

A Novel Dysferlin-Binding Kinase CK2α Promotes Plasma Membrane Repair in Dysferlinopathy.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026
Same author

Prostaglandin E2 receptor EP2 is indispensable for maintenance of skeletal muscle stem cells.

Stem cells (Dayton, Ohio)·2026

相关实验视频

Updated: Jan 17, 2026

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice
08:13

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice

Published on: April 10, 2019

6.4K

基于干细胞/原始细胞治疗杜申尼肌肉发育不良的治疗.

Tsukasa Tominari1, Chaitra Sathyaprakash1, Yoshitsugu Aoki1

  • 1Department of Molecular Therapy, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan.

Frontiers in cell and developmental biology
|September 19, 2025
PubMed
概括

杜氏肌肉发育不良 (DMD) 疗法在肌肉再生方面面临挑战. 干细胞疗法对DMD有希望,重点关注细胞预调和利基治疗,以更好地整合和改善结果.

科学领域:

  • 再生医学是一种再生医学.
  • 分子生物学分子生物学
  • 遗传学 是一个遗传学.

背景情况:

  • 杜氏肌肉发育不良 (DMD) 是一种遗传性疾病,其特征是失去了素,导致渐进的肌肉衰竭和心脏并发症.
  • 目前用于DMD的分子疗法在促进组织再生和减少纤维化方面取得了有限的成功.
  • 基于干细胞/原始细胞的疗法为DMD治疗提供了一个有前途的途径,但移植协议和细胞预处理需要优化.

研究的目的:

  • 审查阻碍DMD中成功肌肉组织再生的挑战.
  • 总结一下DMD的干细胞/原生细胞治疗的最新进展.
  • 突出细胞预调和疾病利基治疗对于改善治疗结果的重要性.

主要方法:

  • 对杜氏肌肉发育不良症的干细胞/原始细胞疗法现有文献的综述.
  • 对DMD治疗研究的不同细胞类型的分析,包括肌源性干细胞/原始细胞,介质干细胞 (MSC) 和诱导多能干细胞 (iPSC).
  • 专注于预先调节策略和疾病利基修改,以增强细胞融合.

主要成果:

  • 肌源性干细胞/原始细胞的目的是恢复DMD肌肉中的肌纤维数量和肌蛋白表达.
  • 介质细胞干细胞 (MSCs) 具有免疫抑制特性,可以补充DMD的基因疗法.
关键词:
心脏肌肉的心脏肌肉杜琴肌肉发育不良 (DMD)消极蛋白质是一种消极蛋白质.这是骨肌肉的骨架肌肉.干细胞疗法 干细胞疗法

更多相关视频

CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors
07:44

CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors

Published on: September 14, 2019

8.8K
Transplantation of Induced Pluripotent Stem Cell-derived Mesoangioblast-like Myogenic Progenitors in Mouse Models of Muscle Regeneration
10:03

Transplantation of Induced Pluripotent Stem Cell-derived Mesoangioblast-like Myogenic Progenitors in Mouse Models of Muscle Regeneration

Published on: January 20, 2014

10.1K

相关实验视频

Last Updated: Jan 17, 2026

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice
08:13

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice

Published on: April 10, 2019

6.4K
CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors
07:44

CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors

Published on: September 14, 2019

8.8K
Transplantation of Induced Pluripotent Stem Cell-derived Mesoangioblast-like Myogenic Progenitors in Mouse Models of Muscle Regeneration
10:03

Transplantation of Induced Pluripotent Stem Cell-derived Mesoangioblast-like Myogenic Progenitors in Mouse Models of Muscle Regeneration

Published on: January 20, 2014

10.1K
  • 成功的DMD肌肉再生需要克服与细胞移植和疾病微观环境相关的特定挑战.

    • 结论:

    • 基于干细胞/原始细胞的疗法为DMD患者的肌肉再生提供了潜在的策略.
    • 优化细胞预调和解决DMD疾病利基对于成功的治疗整合至关重要.
    • 需要进一步的研究来完善这些方法,以有效治疗DMD.